We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+10.5%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.06B
AUM Growth
+$91.6M
Cap. Flow
+$2.42M
Cap. Flow %
0.23%
Top 10 Hldgs %
36.45%
Holding
253
New
7
Increased
46
Reduced
89
Closed
5

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$3.05M
2
VEEV icon
Veeva Systems
VEEV
+$1.43M
3
QCOM icon
Qualcomm
QCOM
+$1.29M
4
CCI icon
Crown Castle
CCI
+$1.08M
5
LRCX icon
Lam Research
LRCX
+$954K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.27M
2
BXMT icon
Blackstone Mortgage Trust
BXMT
+$1.41M
3
CVS icon
CVS Health
CVS
+$1.23M
4
NEE icon
NextEra Energy
NEE
+$735K
5
TFC icon
Truist Financial
TFC
+$629K

Sector Composition

Rank Sector Weight
1 Healthcare 21.11%
2 Technology 20.74%
3 Financials 13.64%
4 Industrials 10.29%
5 Communication Services 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY.RT
201
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$199K 0.02%
88,509
– –
ORI icon
202
Old Republic International
ORI
$10.3B
$173K 0.02%
11,720
– –
WHWK
203
Whitehawk Therapeutics
WHWK
$259M
$150K 0.01%
6,667
– –
MNDT
204
DELISTED
Mandiant, Inc. Common Stock
MNDT
$149K 0.01%
12,050
-7,600
-39% -$104K
MFC icon
205
Manulife Financial
MFC
$73.3B
$148K 0.01%
10,660
– –
PBCT
206
DELISTED
People's United Financial Inc
PBCT
$130K 0.01%
12,595
-1,417
-10% -$15.4K
MRO
207
DELISTED
Marathon Oil Corporation
MRO
$122K 0.01%
29,786
-350
-1% -$1.85K
NTRP
208
DELISTED
Neurotrope, Inc. Common
NTRP
$121K 0.01%
109,375
– –
PAA icon
209
Plains All American Pipeline
PAA
$16.4B
$96K 0.01%
16,000
– –
NRT
210
North European Oil Royalty Trust
NRT
$83.5M
$83K 0.01%
27,999
– –
MRKR icon
211
Marker Therapeutics
MRKR
$19.2M
$45K ﹤0.01%
3,010
– –
XCUR icon
212
Exicure
XCUR
$8.73M
$29K ﹤0.01%
111
– –
MTNB icon
213
Matinas BioPharma
MTNB
$1.72M
$13K ﹤0.01%
350
– –
CTVA icon
214
Corteva
CTVA
$51B
– –
-11,037
Closed -$296K
EOG icon
215
EOG Resources
EOG
$74.6B
– –
-5,320
Closed -$269K
HES
216
DELISTED
Hess
HES
– –
-4,275
Closed -$221K
IAT icon
217
iShares US Regional Banks ETF
IAT
$678M
– –
-6,850
Closed -$232K
SU icon
218
Suncor Energy
SU
$73.4B
– –
-13,023
Closed -$219K
5 6 7 8
9

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q3 2020 Portfolio in Review

As of Q3 2020, Neville Rodie & Shaw held 253 positions worth $1.06B, up 9.5% from $968M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q3 2020: portfolio turnover was 4.7%. Neville Rodie & Shaw opened 7 new positions and exited 5, leaving the 253-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • Neville Rodie & Shaw's largest Q3 2020 buy was Crown Castle: 6,550 shares worth $1.09M.
  • Neville Rodie & Shaw added most to Costco in Q3 2020, an estimated $3.05M increase.
  • Neville Rodie & Shaw's biggest Q3 2020 reduction was Apple, cutting an estimated $2.27M.
  • Neville Rodie & Shaw fully exited Corteva in Q3 2020, selling an estimated $296K.
  • Neville Rodie & Shaw's ten largest holdings make up 36% of its $1.06B portfolio in Q3 2020.
  • Neville Rodie & Shaw opened 7 new positions and closed 5 in Q3 2020.
  • Neville Rodie & Shaw's portfolio value rose 9.5% quarter-over-quarter to $1.06B.

Based on Neville Rodie & Shaw's 13F filing for Q3 2020, filed 1 Oct 2020.